1. EMEA (European Agency for the Evaluation of Medicinal Products), 2002. Note for guidance on carcinogenic potential. CPMP/SWP/2877/00. Last retrieved April 17, 2009, from EMEA website at 〈http://www.emea.europa.eu/pdfs/human/swp/287700en.pdf〉.
2. Ettlin RA, Bolon B, Pyrah I, Konishi Y, Black HE. Global recognition of qualified toxicologic pathologists: Where we are now and where we need to go. Published in parallel [with minor variations] as J Toxicol Pathol 2007;20:267–72. Exp Toxicol Pathol 2008;60:1–8. Toxicol Pathol 2008;36:753–9.
3. FDA (United States Food and Drug Administration), 2004. Good laboratory practice for nonclinical laboratory studies. 21CFR58.29. Last retrieved April 17, 2009, from FDA website at 〈http://edocket.access.gpo.gov/cfr_2004/aprqtr/21cfr58.29.htm〉.
4. IATP-International Academy of Toxicologic Pathology. Last retrieved April 17, 2009, from IATP website at 〈http://www.iatpfellows.org/〉.
5. IFSTP – International Federation of Societies of Toxicologic Pathologists. Last retrieved April 17, 2009, from IFSTP website at 〈http://ifstp.org/〉.